NOS1, nitric oxide synthase 1, 4842

N. diseases: 521; N. variants: 38
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 Biomarker disease BEFREE S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction. 29736011 2018
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 AlteredExpression disease BEFREE Our findings indicate that aging decreases penile NOS expression, neurogenic and endothelium-dependent relaxations of CC, and also suppresses serum testosterone levels by inducing inflammatory response that may contribute to the development of ED. 29260891 2018
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 AlteredExpression disease BEFREE These findings support that UCMS decreases penile constitutive NOS expression via TNF-α, which may contribute to the development of ED. 27904147 2017
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 GeneticVariation disease BEFREE CONCLUSIONS The findings indicate a decreased risk of ED in patients with CP who are carriers of miR-146a rs2910164 C allele, and this association might be due to its ability to compromise the expression of miR-146a, and thereby increase the expression of its target gene, NOS1. 28218896 2017
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 GeneticVariation disease BEFREE NOS1 polymorphisms are associated with responsiveness to sildenafil in ED. 24897285 2014
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 Therapeutic disease RGD Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)brain-derived neurotrophic factor (BDNF)-membrane system in a rat model of cavernous nerve injury. 23522997 2013
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 Therapeutic disease RGD Evaluation of the effect of different doses of low energy shock wave therapy on the erectile function of streptozotocin (STZ)-induced diabetic rats. 23698784 2013
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 Biomarker disease RGD Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunction. 23535456 2013
CUI: C0242350
Disease: Erectile dysfunction
Erectile dysfunction
0.260 AlteredExpression disease BEFREE Based on animal and cell studies, neurogenic ED is assumed to be caused mainly by: (a) an insufficient synthesis of nitric oxide (NO) due to a decrease in the levels of the penile neuronal nitric oxide synthase (PnNOS) or the impairment of its regulation by protein effectors (NMDA receptor, protein inhibitor of nNOS: PIN), occurring in the neuronal bodies or nerve terminals, or (b) a loss of the cells themselves by apoptosis caused by the induction of inducible NOS (iNOS) and the production of peroxynitrite. 15582286 2005